Concerns on Bebtelovimab (LY-CoV1404) used to neutralize Omicron subvariants. Wang X, Yang Y, Song Z, Wang Y, et al. J Med Virol 2023 Feb 9. doi: 10.1002/jmv.28565.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Wang X, Yang Y, Song Z, Wang Y, et al. Concerns on Bebtelovimab (LY-CoV1404) used to neutralize Omicron subvariants. J Med Virol 2023 Feb 9. doi: 10.1002/jmv.28565.
PMID: 36756927